Dopamine Agonists [phsu]
PREVENT [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
Background [cnce]
Ovarian Hyperstimulation Syndrome [dsyn]
Serious [qlco]
Complication [patf]
Ovarian Stimulation [topp]
Assisted [fndg]
genetic technology [mbrt]
enlarged ovaries [fndg]
acute [tmco]
fluid shift [phsf]
Intravascular [spco]
Space [spco]
Third [qnco]
Space [spco]
Bloating [sosy]
Increased [qnco]
Risk [qlco]
Venous Thromboembolism [patf]
Decreased [qnco]
Organ [bpoc]
Perfusion [topp]
Cases [ftcn]
Mild [qlco]
Form [qlco]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
APPEAR [qlco]
In Vitro Fertilization [topp]
IVF [topp]
Cycle [tmco]
Dopamine Agonist [phsu]
cabergoline [orch, phsu]
introduce [ftcn]
Secondary Prevention [topp]
intervention [hlca]
Ovarian Hyperstimulation Syndrome [dsyn]
Women [popg]
High Risk [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Assisted [fndg]
Reproduction [orgf]
Technology [ocdi]
treatment [ftcn]
cabergoline [orch, phsu]
To [qlco]
effective [qlco]
PREVENT [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
Types [qlco]
Dopamine Agonists [phsu]
quinagolide [orch, phsu]
Bromocriptin [orch, phsu]
Since [tmco]
Study [mnob]
Assisted [fndg]
genetic technology [mbrt]
PREVENT [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
objectives [inpr]
To [qlco]
Assess [acty]
Effectiveness [qlco]
Safety [hcpp]
Dopamine Agonists [phsu]
PREVENT [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
High Risk [qlco]
Women [popg]
Assisted [fndg]
genetic technology [mbrt]
treatment [ftcn]
search [inpr]
Methods [inpr]
Searched [acty]
Several [qnco]
Databases [inpr]
Gynaecology [bmod]
Fertility [orgf]
specialised [qlco]
Trial [resa]
Central [spco]
Controlled [ftcn]
Trial [resa]
MEDLINE [inpr]
GOV [gngm]
World Health Organization [hcro]
International [idcn]
Trial [resa]
Registry [inpr]
Platform [resd]
Controlled [ftcn]
Trial [resa]
Assess [acty]
Effect [qlco]
Dopamine Agonist [phsu]
PREVENT [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
Reference [idcn]
List [cnce]
Relevant [qlco]
studies [lbpr]
Selection Criteria [qlco]
considered [idcn]
Controlled [ftcn]
Trial [resa]
Compared [acty]
Dopamine Agonists [phsu]
placebo [topp]
intervention [hlca]
intervention [hlca]
PREVENT [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
High Risk [qlco]
Women [popg]
Inclusion [qlco]
Primary Outcome Measure [inpr]
Incidence [qnco]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Live [qlco]
Birth Rate [qnco]
secondary [neop]
endpoints [qlco]
Clinical [qlco]
Pregnancy Rate [qnco]
Multiple Pregnancy [patf]
Rate [acty]
Miscarriage [patf]
Rate [acty]
adverse effects [ftcn]
treatment [ftcn]
Data Collection [resa]
Analysis [lbpr]
Two [qnco]
Authors [prog]
screen [hlca]
Title [idcn]
Abstracts [inpr]
Full [qlco]
Text [inpr]
Publications [inpr, mnob]
Select [acty]
studies [lbpr]
Extracted [topp]
Data [idcn]
Assessed [acty]
Risk [qlco]
Bias [idcn]
Resolved [idcn]
Disagreement [socb]
Consensus [socb]
Reported [inpr]
Pooled [cnce]
Result [ftcn]
Odds Ratios [qnco]
Confidence Interval [qnco]
Method [inpr]
Addition [ftcn]
Grade [clas]
Overall [inpr]
Quality [qlco]
Evidence [ftcn]
Using [ftcn]
Grade [clas]
criteria [inpr]
Main [qlco]
Result [ftcn]
search [inpr]
Identified [qlco]
New [tmco]
Controlled [ftcn]
Trial [resa]
Last [qlco]
Published [ocac]
Version [ftcn]
Review [inpr]
included [ftcn]
Controlled [ftcn]
Trial [resa]
Involving [ftcn]
High Risk [qlco]
Women [popg]
Update [tmco]
Review [inpr]
Evaluated [ftcn]
Three [qnco]
Types [qlco]
Dopamine Agonists [phsu]
cabergoline [orch, phsu]
quinagolide [orch, phsu]
Bromocriptin [orch, phsu]
Compared [acty]
placebo [topp]
intervention [hlca]
Dopamine Agonists [phsu]
effective [qlco]
Prevention [topp]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Odds Ratios [qnco]
Confidence Interval [qnco]
participants [popg]
studies [lbpr]
I- [inch]
Moderate [qlco]
Quality [qlco]
Evidence [ftcn]
This [euka]
Suggest [idcn]
Women [popg]
Assisted [fndg]
genetic technology [mbrt]
experience [menp]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Dopamine Agonists [phsu]
Lower [spco]
Women [popg]
Evidence [ftcn]
Live [qlco]
Birth Rate [qnco]
Clinical [qlco]
Pregnancy Rate [qnco]
Multiple Pregnancy [patf]
Rate [acty]
Miscarriage [patf]
Rate [acty]
Very low [fndg]
Moderate [qlco]
Quality [qlco]
Evidence [ftcn]
Take [hlca]
Dopamine Agonists [phsu]
quinagolide [orch, phsu]
Increase [ftcn]
Incidence [qnco]
adverse events [fndg]
gastrointestinal [spco]
adverse effects [ftcn]
Odds Ratios [qnco]
Confidence Interval [qnco]
participants [popg]
studies [lbpr]
I- [inch]
Very low [fndg]
Quality [qlco]
Evidence [ftcn]
Compared [acty]
Dopamine Agonist [phsu]
Plus [qlco]
intervention [hlca]
intervention [hlca]
Evidence [ftcn]
Outcome [ftcn]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Live [qlco]
Birth Rate [qnco]
Clinical [qlco]
Pregnancy Rate [qnco]
Miscarriage [patf]
Rate [acty]
adverse events [fndg]
interventions [hlca]
HYDROXYETHYL STARCH [carb, phsu]
Two [qnco]
Controlled [ftcn]
Trial [resa]
Albumin [aapp, bacs]
One [qnco]
cabergoline [orch, phsu]
Associated [qlco]
Low Risk [fndg]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Compared [acty]
human albumin [aapp, phsu]
Odds Ratios [qnco]
Confidence Interval [qnco]
participants [popg]
studies [lbpr]
I- [inch]
Evidence [ftcn]
cabergoline [orch, phsu]
HYDROXYETHYL STARCH [carb, phsu]
Ovarian Stimulation [topp]
Few [qnco]
days [tmco]
prednisolone [phsu, strd]
Increased [qnco]
Clinical [qlco]
Pregnancy Rate [qnco]
cabergoline [orch, phsu]
Group [idcn]
cabergoline [orch, phsu]
Compared [acty]
Odds Ratios [qnco]
Confidence Interval [qnco]
participants [popg]
studies [lbpr]
I- [inch]
respects [socb]
Evidence [ftcn]
Clinical [qlco]
Pregnancy Rate [qnco]
Multiple Pregnancy [patf]
Rate [acty]
Miscarriage [patf]
Rate [acty]
cabergoline [orch, phsu]
Active [ftcn]
interventions [hlca]
Quality [qlco]
Evidence [ftcn]
Dopamine Agonist [phsu]
placebo [topp]
intervention [hlca]
Range [qnco]
low [qlco]
Moderate [qlco]
Poor [grpa]
Reporting [hlca]
Study [mnob]
Methods [inpr]
lack [qlco]
Details [qlco]
Randomization [resa]
Blinding [resa]
Serious [qlco]
IMPRECISION [phpr]
Comparison [acty]
Authors [prog]
Conclusions [idcn]
Dopamine Agonists [phsu]
APPEAR [qlco]
To [qlco]
Incidence [qnco]
Moderate [qlco]
Severe [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Women [popg]
High Risk [qlco]
Ovarian Hyperstimulation Syndrome [dsyn]
Moderate [qlco]
Quality [qlco]
Evidence [ftcn]
If [qlco]
Fresh embryo [emst]
Transfer [menp]
Performed [ftcn]
Dopamine Agonists [phsu]
Not [ftcn]
Affect [menp]
Pregnancy Outcome [fndg]
Live [qlco]
Birth Rate [qnco]
Clinical [qlco]
Pregnancy Rate [qnco]
Miscarriage [patf]
Rate [acty]
Very low [fndg]
Moderate [qlco]
Quality [qlco]
Evidence [ftcn]
Dopamine Agonists [phsu]
Increase [ftcn]
Risk [qlco]
adverse events [fndg]
Gastrointestinal symptoms NOS [sosy]
Further [spco]
Focus [spco]
Dose [qnco]
Finding [sosy]
Comparison [acty]
effectiveness treatment [qlco]
consideration [fndg]
Combination [qlco]
Treatments [topp]
Large [qnco]
Well [qlco]
Design [acty]
Well [qlco]
Executed [acty]
Controlled [ftcn]
Trial [resa]
More [ftcn]
Clinical Endpoint [clna]
Live [qlco]
Birth Rate [qnco]
Further [spco]
Evaluate [ftcn]
Role [socb]
Dopamine Agonists [phsu]
Ovarian Hyperstimulation Syndrome [dsyn]
Prevention [topp]
